Time Zone Change Syndrome Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Time zone change syndrome is also called as desynchronosis or Jet lag. It happens to people who travel frequently across different time zones. It can cause headaches, insomnia, and irritability.
MARKET SCOPE
The "Global Time Zone Change Syndrome Treatment Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the time zone change syndrome treatment market with detailed market segmentation by drug class, distribution channel, and geography. The report provides key statistics on the market status of the leading Time Zone Change Syndrome Treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug class, the global time zone change syndrome treatment market is segmented into prescription drugs, and OTC drugs. Based on prescription drugs, the market is further sub segmented into non-benzodiazepines, and benzodiazepines. Based on OTC drugs, the market is further sub segmented into diphenhydramine, doxylamine, melatonin, and herbal and natural products.
- On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online sales.
Drivers-
- Increasing number of air travelers.
- Growing adoption of advanced treatment technology including wearable and portable light therapy devices.
- Rise in international tourism.
- Drug abuse and addiction
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Time Zone Change Syndrome Treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Time Zone Change Syndrome Treatment market in these regions.
IMPACT OF COVID-19 ON TIME ZONE CHANGE SYNDROME TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Tourism and hospitality businesses have been profoundly affected by COVID-19. International tourism has been highly affected due to travel bans on account of growing cases. Therefore, the COVID-19 has negatively impacted the growth if the time zone change syndrome treatment market.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Time Zone Change Syndrome Treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Time Zone Change Syndrome Treatment market in these regions.
IMPACT OF COVID-19 ON TIME ZONE CHANGE SYNDROME TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Tourism and hospitality businesses have been profoundly affected by COVID-19. International tourism has been highly affected due to travel bans on account of growing cases. Therefore, the COVID-19 has negatively impacted the growth if the time zone change syndrome treatment market.
MARKET PLAYERS
The report covers key developments in the Time Zone Change Syndrome Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Time Zone Change Syndrome Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Time Zone Change Syndrome Treatment in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Time Zone Change Syndrome Treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Clinigen Group plc
- Vanda Pharmaceuticals Inc
- Pfizer Inc
- Jamieson Laboratories Ltd
- NOW Foods
- Nature's Bounty
- ALEXZA
- Jazz Pharmaceuticals, Inc
- Eisai Co., Ltd
- Purdue Pharma L.P
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Time Zone Change Syndrome Treatment Market - By Drug Class
1.3.2 Time Zone Change Syndrome Treatment Market - By Distribution Channel
1.3.3 Time Zone Change Syndrome Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TIME ZONE CHANGE SYNDROME TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TIME ZONE CHANGE SYNDROME TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TIME ZONE CHANGE SYNDROME TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. TIME ZONE CHANGE SYNDROME TREATMENT - GLOBAL MARKET OVERVIEW
6.2. TIME ZONE CHANGE SYNDROME TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TIME ZONE CHANGE SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. PRESCRIPTION DRUGS
7.3.1. Overview
7.3.2. Prescription Drugs Market Forecast and Analysis
7.4. OTC DRUGS
7.4.1. Overview
7.4.2. OTC Drugs Market Forecast and Analysis
8. TIME ZONE CHANGE SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE SALES
8.5.1. Overview
8.5.2. Online Sales Market Forecast and Analysis
9. TIME ZONE CHANGE SYNDROME TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Time Zone Change Syndrome Treatment Market Overview
9.1.2 North America Time Zone Change Syndrome Treatment Market Forecasts and Analysis
9.1.3 North America Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Drug Class
9.1.4 North America Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Time Zone Change Syndrome Treatment Market
9.1.5.1.1 United States Time Zone Change Syndrome Treatment Market by Drug Class
9.1.5.1.2 United States Time Zone Change Syndrome Treatment Market by Distribution Channel
9.1.5.2 Canada Time Zone Change Syndrome Treatment Market
9.1.5.2.1 Canada Time Zone Change Syndrome Treatment Market by Drug Class
9.1.5.2.2 Canada Time Zone Change Syndrome Treatment Market by Distribution Channel
9.1.5.3 Mexico Time Zone Change Syndrome Treatment Market
9.1.5.3.1 Mexico Time Zone Change Syndrome Treatment Market by Drug Class
9.1.5.3.2 Mexico Time Zone Change Syndrome Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Time Zone Change Syndrome Treatment Market Overview
9.2.2 Europe Time Zone Change Syndrome Treatment Market Forecasts and Analysis
9.2.3 Europe Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Time Zone Change Syndrome Treatment Market
9.2.5.1.1 Germany Time Zone Change Syndrome Treatment Market by Drug Class
9.2.5.1.2 Germany Time Zone Change Syndrome Treatment Market by Distribution Channel
9.2.5.2 France Time Zone Change Syndrome Treatment Market
9.2.5.2.1 France Time Zone Change Syndrome Treatment Market by Drug Class
9.2.5.2.2 France Time Zone Change Syndrome Treatment Market by Distribution Channel
9.2.5.3 Italy Time Zone Change Syndrome Treatment Market
9.2.5.3.1 Italy Time Zone Change Syndrome Treatment Market by Drug Class
9.2.5.3.2 Italy Time Zone Change Syndrome Treatment Market by Distribution Channel
9.2.5.4 Spain Time Zone Change Syndrome Treatment Market
9.2.5.4.1 Spain Time Zone Change Syndrome Treatment Market by Drug Class
9.2.5.4.2 Spain Time Zone Change Syndrome Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Time Zone Change Syndrome Treatment Market
9.2.5.5.1 United Kingdom Time Zone Change Syndrome Treatment Market by Drug Class
9.2.5.5.2 United Kingdom Time Zone Change Syndrome Treatment Market by Distribution Channel
9.2.5.6 Rest of Europe Time Zone Change Syndrome Treatment Market
9.2.5.6.1 Rest of Europe Time Zone Change Syndrome Treatment Market by Drug Class
9.2.5.6.2 Rest of Europe Time Zone Change Syndrome Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Time Zone Change Syndrome Treatment Market Overview
9.3.2 Asia-Pacific Time Zone Change Syndrome Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Time Zone Change Syndrome Treatment Market
9.3.5.1.1 Australia Time Zone Change Syndrome Treatment Market by Drug Class
9.3.5.1.2 Australia Time Zone Change Syndrome Treatment Market by Distribution Channel
9.3.5.2 China Time Zone Change Syndrome Treatment Market
9.3.5.2.1 China Time Zone Change Syndrome Treatment Market by Drug Class
9.3.5.2.2 China Time Zone Change Syndrome Treatment Market by Distribution Channel
9.3.5.3 India Time Zone Change Syndrome Treatment Market
9.3.5.3.1 India Time Zone Change Syndrome Treatment Market by Drug Class
9.3.5.3.2 India Time Zone Change Syndrome Treatment Market by Distribution Channel
9.3.5.4 Japan Time Zone Change Syndrome Treatment Market
9.3.5.4.1 Japan Time Zone Change Syndrome Treatment Market by Drug Class
9.3.5.4.2 Japan Time Zone Change Syndrome Treatment Market by Distribution Channel
9.3.5.5 South Korea Time Zone Change Syndrome Treatment Market
9.3.5.5.1 South Korea Time Zone Change Syndrome Treatment Market by Drug Class
9.3.5.5.2 South Korea Time Zone Change Syndrome Treatment Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Time Zone Change Syndrome Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Time Zone Change Syndrome Treatment Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Time Zone Change Syndrome Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Time Zone Change Syndrome Treatment Market Overview
9.4.2 Middle East and Africa Time Zone Change Syndrome Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Time Zone Change Syndrome Treatment Market
9.4.5.1.1 South Africa Time Zone Change Syndrome Treatment Market by Drug Class
9.4.5.1.2 South Africa Time Zone Change Syndrome Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Time Zone Change Syndrome Treatment Market
9.4.5.2.1 Saudi Arabia Time Zone Change Syndrome Treatment Market by Drug Class
9.4.5.2.2 Saudi Arabia Time Zone Change Syndrome Treatment Market by Distribution Channel
9.4.5.3 U.A.E Time Zone Change Syndrome Treatment Market
9.4.5.3.1 U.A.E Time Zone Change Syndrome Treatment Market by Drug Class
9.4.5.3.2 U.A.E Time Zone Change Syndrome Treatment Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Time Zone Change Syndrome Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Time Zone Change Syndrome Treatment Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Time Zone Change Syndrome Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Time Zone Change Syndrome Treatment Market Overview
9.5.2 South and Central America Time Zone Change Syndrome Treatment Market Forecasts and Analysis
9.5.3 South and Central America Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Time Zone Change Syndrome Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Time Zone Change Syndrome Treatment Market
9.5.5.1.1 Brazil Time Zone Change Syndrome Treatment Market by Drug Class
9.5.5.1.2 Brazil Time Zone Change Syndrome Treatment Market by Distribution Channel
9.5.5.2 Argentina Time Zone Change Syndrome Treatment Market
9.5.5.2.1 Argentina Time Zone Change Syndrome Treatment Market by Drug Class
9.5.5.2.2 Argentina Time Zone Change Syndrome Treatment Market by Distribution Channel
9.5.5.3 Rest of South and Central America Time Zone Change Syndrome Treatment Market
9.5.5.3.1 Rest of South and Central America Time Zone Change Syndrome Treatment Market by Drug Class
9.5.5.3.2 Rest of South and Central America Time Zone Change Syndrome Treatment Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TIME ZONE CHANGE SYNDROME TREATMENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. TIME ZONE CHANGE SYNDROME TREATMENT MARKET, KEY COMPANY PROFILES
12.1. CLINIGEN GROUP PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. VANDA PHARMACEUTICALS INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JAMIESON LABORATORIES LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOW FOODS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NATURE’S BOUNTY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ALEXZA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JAZZ PHARMACEUTICALS, INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EISAI CO., LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PURDUE PHARMA L.P
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
1. Clinigen Group plc
2. Vanda Pharmaceuticals Inc
3. Pfizer Inc
4. Jamieson Laboratories Ltd
5. NOW Foods
6. Nature's Bounty
7. ALEXZA
8. Jazz Pharmaceuticals, Inc
9. Eisai Co., Ltd
10. Purdue Pharma L.P
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For